DelphX Arranges Non-Brokered Unit Private Placement

Q: How will DelphX (DPXCF) use the proceeds from its August 2026 private placement?

DelphX plans to use the net proceeds for general corporate purposes . According to DelphX, the non-brokered unit private placement is expected to provide up to $80,000 in gross proceeds, supporting ongoing operations and corporate activities as determined by management.

Q: Are there any regulatory or holding restrictions on the new DelphX (DPXCF) securities?

Completion of the offering is subject to TSX Venture Exchange approval . According to DelphX, securities issued under the private placement will be subject to a hold period of four months plus one day from the date of issuance, limiting immediate resale.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

DelphX Capital Markets (OTCQB: DPXCF, TSXV: DELX) has revised its previously announced non-brokered financing and will no longer proceed with the convertible debenture component. The company now plans only a non-brokered private placement of up to 8,000,000 units at $0.01 per unit, for maximum gross proceeds of $80,000.

Each unit comprises one common share and one warrant, with each warrant exercisable at $0.06 for two years. Completion is subject to TSX Venture Exchange approval, and securities will carry a four-month-plus-one-day hold period. According to DelphX, net proceeds will be used for general corporate purposes.

Positive

Equity financing up to $80,000 via 8,000,000 units at $0.01
Two-year warrants at $0.06 may provide additional future capital if exercised

Negative

Potential dilution from issuing up to 8,000,000 new shares plus associated warrants

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/04/2026 - 05:55 PM

Toronto, Ontario and New York, New York--(Newsfile Corp. - August 4, 2026) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX" or the "Company")

Non-brokered private placement

DelphX Capital Markets Inc. ("DelphX" or the "Company") arranges that it is revising the unit private placement component of the non-brokered financing previously announced on July 20, 2026. As disclosed in the Company's July 20, 2026 news release titled "DelphX Announces Non-Brokered Unit Private Placement and Convertible Debenture Financing," the previously announced financing included a unit private placement and a non-brokered private placement of convertible debentures. In connection with that revision, the previously announced convertible debenture component of the financing will no longer proceed.

The Company now intends to only complete the private placement of up to 8,000,000 units of the Company (the "Units") at a subscription price of $0.01 per Unit, for gross proceeds of up to $80,000.

Each Unit will consist of one common share of the Company and one common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to acquire one additional common share of the Company at an exercise price of $0.06 for a period of two years from the date of issuance.

In connection with the offering, Delphx may elect to pay finders' fees to eligible finders and details of any finders' fees paid will be announced at a later date.

Completion of the offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the offering will be subject to a hold period of four months plus one day from the date of issuance.

Delphx intends to use the net proceeds from the offering in connection with general corporate purposes.

About Delphx Capital Markets Inc.

Delphx is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special-purpose vehicle, Quantem LLC, the company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new Delphx securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by U.S. Bank. CPOs and CRNs are proprietary products created and owned by Delphx Capital Markets.

For further information, please contact:

George Wentworth, General Manager
Delphx Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable Canadian securities laws, including statements regarding the proposed non-brokered private placement and the intended use of proceeds. Forward-looking information is based on the Company's current expectations and assumptions and is subject to risks and uncertainties that could cause actual results to differ materially, including the risk that the offering is not completed on the terms contemplated or at all, or that regulatory approval from the TSX Venture Exchange is not obtained. Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this release. The Company undertakes no obligation to update such information except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/308054

FAQ

What is DelphX Capital Markets (DPXCF) announcing in its August 4, 2026 private placement?

DelphX is arranging a non-brokered private placement of up to 8,000,000 units at $0.01 per unit, for gross proceeds of up to $80,000. According to DelphX, each unit includes one share and one warrant exercisable at $0.06 for two years.

What are the terms of the DPXCF private placement units and warrants?

Each DelphX unit includes one common share and one common share purchase warrant. According to DelphX, each warrant allows the holder to buy one additional share at an exercise price of $0.06 for two years from issuance, potentially adding future equity capital.

What happened to the previously announced convertible debenture financing for DelphX (DPXCF)?

The previously announced non-brokered convertible debenture component will no longer proceed. According to DelphX, the revised financing now consists solely of the unit private placement, focusing on issuing equity units rather than convertible debentures under the updated structure.

How will DelphX (DPXCF) use the proceeds from its August 2026 private placement?

DelphX plans to use the net proceeds for general corporate purposes. According to DelphX, the non-brokered unit private placement is expected to provide up to $80,000 in gross proceeds, supporting ongoing operations and corporate activities as determined by management.

Are there any regulatory or holding restrictions on the new DelphX (DPXCF) securities?

Completion of the offering is subject to TSX Venture Exchange approval. According to DelphX, securities issued under the private placement will be subject to a hold period of four months plus one day from the date of issuance, limiting immediate resale.

Will DelphX (DPXCF) pay any finders' fees on this non-brokered private placement?

DelphX may elect to pay finders' fees to eligible finders in connection with the offering. According to DelphX, details of any finders' fees paid will be announced later, indicating terms are not yet finalized or publicly specified.